Clindamycin Hydrochloride Global Market Report 2025
상품코드:1816798
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
클린다마이신 염산염 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에 CAGR은 8.2%를 나타낼 것으로 예측되고 27억 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 고급 의약품 제형 및 전달 방식의 발전, 부작용이 적은 표적 항생제에 대한 수요 증가, 의료 인프라 및 의약품 접근성에 대한 투자 확대, 전 세계 항생제 내성 감염의 유병률 증가, 신흥 시장에서 클린다마이신의 사용 확대 등에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 클린다마이신이 포함된 복합 요법으로의 전환, 클린다마이신 기반 국소 제형 개발 증가, 전략적 제휴 및 인수를 통한 시장 점유율 확대, 수의학 분야에서의 클린다마이신 용도 확대, 맞춤형 의약품 및 개별화된 항생제 치료에 대한 강조 증가 등이 있습니다.
향후 5년간 8.2% 성장이라는 예측치는 이 시장에 대한 이전 추정치 대비 0.3% 소폭 하향 조정된 수치입니다. 이러한 감소는 주로 미국과 타국 간 관세 영향 때문입니다. 미국은 인도 및 중국산 원 의약품(API) 및 중간체에 대한 관세로 항생제 제조 비용 구조가 교란되면서 의약품 생산 비용이 증가할 수 있습니다. 또한 상호 보복 관세와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 효과가 더 광범위하게 될 것입니다.
피부 감염 및 여드름 발생률 증가가 클린다마이신 염산염 시장을 촉진할 것으로 전망됩니다. 이러한 증가는 주로 오염 심화, 호르몬 변동, 생활 방식 선택과 관련된 스트레스 등의 요인에 기인합니다. 클린다마이신 염산염은 항균 특성으로 인해 피부 감염 및 여드름 치료에 활용되며, 염증을 유발하는 세균 증식을 효과적으로 표적화하여 억제합니다. 예를 들어, 2022년 5월 영국에 본사를 둔 약국 및 개인 온라인 클리닉인 Click2pharmacy는 잉글랜드의 CCG(Clinical Commissioning Groups)가 2021년 2월부터 2022년 1월 사이에 총액 2,267만 파운드(2,933만 달러)에 해당합니다. 따라서 피부 감염과 여드름 유병률 증가는 클린다마이신 염산염 시장의 성장을 뒷받침하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 클린다마이신 염산염 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 클린다마이신 염산염 시장 : 성장률 분석
세계의 클린다마이신 염산염 시장 실적 : 규모와 성장(2019-2024년)
세계의 클린다마이신 염산염 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 클린다마이신 염산염 : 총 잠재시장 규모(TAM)
제6장 시장 세분화
세계의 클린다마이신 염산염 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
외용
정맥 주사
세계의 클린다마이신 염산염 시장 : 적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
여드름 치료
세균 감염증
뼈 및 관절 감염
기타 감염증
세계의 클린다마이신 염산염 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 클린다마이신 염산염 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 클린다마이신 염산염 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
클린다마이신 염산염 시장 : 경쟁 구도
클린다마이신 염산염 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Fresenius SE & Co. KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Viatris Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Baxter International Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Teva Pharmaceutical Industries Ltd.
Sandoz International GmbH
Bausch Health Companies Inc.
Hetero Drugs Limited
Sun Pharmaceutical Industries Ltd.
Douglas Group
Aurobindo Pharma Limited
Dr. Reddy's Laboratories Ltd.
Cipla Limited
Apotex Inc.
Amneal Pharmaceuticals
Lupin Limited
Zydus Lifesciences Ltd.
Alkem Laboratories Ltd.
Torrent Pharmaceuticals Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
클린다마이신 염산염 시장(2029년) : 새로운 기회를 제공하는 국가
클린다마이신 염산염 시장(2029년) : 새로운 기회를 제공하는 부문
클린다마이신 염산염 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Clindamycin hydrochloride is an antibiotic utilized to treat a range of bacterial infections, particularly those caused by anaerobic bacteria, as well as certain protozoal infections. It functions by inhibiting bacterial protein synthesis, thereby halting bacterial growth. This medication is commonly prescribed for skin, respiratory, bone, and joint infections, and it is also effective in treating acne and dental infections. Clindamycin hydrochloride is available in oral, topical, and injectable forms.
The primary forms of clindamycin hydrochloride include oral, topical, and intravenous injections. Oral administration involves taking the medication by mouth, where it is absorbed through the digestive system into the bloodstream. Oral clindamycin hydrochloride is available in capsules or tablets and is mainly used to treat various bacterial infections, including those affecting the skin and respiratory tract. Indications for use include the treatment of acne, bacterial infections, bone and joint infections, and other infectious diseases, with applications found in hospitals, drugstores, and other healthcare settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a notable impact on the services sector, particularly in business services, IT, and professional consulting. The increased costs of imported technology, office equipment, and critical digital infrastructure are driving up operating expenses for service providers, compelling them to either pass these costs on to clients or absorb the financial strain themselves. Outsourcing firms and IT service providers are grappling with higher hardware costs and supply chain delays, which are disrupting project timelines and squeezing profitability. Furthermore, retaliatory tariffs have weakened demand for U.S.-based professional services in key global markets, slowing export-driven revenues. To navigate these challenges, the sector must focus on accelerating digital transformation, optimizing costs, and strengthening domestic client relationships to sustain growth and remain competitive in an increasingly uncertain trade environment.
The clindamycin hydrochloride market research report is one of a series of new reports from The Business Research Company that provides clindamycin hydrochloride market statistics, including clindamycin hydrochloride industry global market size, regional shares, competitors with a clindamycin hydrochloride market share, detailed clindamycin hydrochloride market segments, market trends and opportunities, and any further data you may need to thrive in the clindamycin hydrochloride industry. This clindamycin hydrochloride market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The clindamycin hydrochloride market size has grown strongly in recent years. It will grow from $1.82 billion in 2024 to $1.97 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to the rising prevalence of bacterial infections, increasing usage of clindamycin in the treatment of anaerobic infections, growing adoption in surgical prophylaxis, rising awareness and diagnosis of skin and soft tissue infections, and increasing recommendations by healthcare professionals due to its effectiveness against resistant strains.
The clindamycin hydrochloride market size is expected to see strong growth in the next few years. It will grow to $2.7 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to advances in pharmaceutical formulations and delivery methods, growing demand for targeted antibiotics with fewer side effects, increasing investment in healthcare infrastructure and access to medications, rising prevalence of antibiotic-resistant infections globally, and expanding use of clindamycin in emerging markets. Major trends in the forecast period include a shift towards combination therapies including clindamycin, growth in the development of clindamycin-based topical formulations, increasing market presence due to strategic partnerships and acquisitions, expansion of clindamycin applications in veterinary medicine, and growing emphasis on personalized medicine and tailored antibiotic treatments.
The forecast of 8.2% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The U.S. may encounter higher pharmaceutical production costs as tariffs on active pharmaceutical ingredients and intermediate compounds sourced from India and China disrupt the cost structure of antibiotic manufacturing. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of skin infections and acne is projected to drive the growth of the clindamycin hydrochloride market. This increase is primarily attributed to factors such as heightened pollution, hormonal fluctuations, and stress related to lifestyle choices. Clindamycin hydrochloride is utilized in treating skin infections and acne due to its antibacterial properties, which effectively target and diminish bacterial growth that leads to inflammation. For example, in May 2022, Click2pharmacy, a UK-based pharmacy and private online clinic, reported that Clinical Commissioning Groups (CCGs) in England prescribed a total of 1.52 million topical acne treatments valued at £22.67 million ($29.33 million) between February 2021 and January 2022. Therefore, the rising prevalence of skin infections and acne is fueling the growth of the clindamycin hydrochloride market.
Key players in the clindamycin hydrochloride market are concentrating on the development of novel products, such as generic formulations of clindamycin hydrochloride capsules, to establish a competitive edge. These generic capsules serve as prescription medications for treating bacterial infections and offer a cost-effective alternative to brand-name products. They are employed to address various infections, including those affecting the skin, respiratory tract, and soft tissues. For instance, in March 2023, Glenmark Pharmaceuticals, an India-based pharmaceutical company, received final approval from the U.S. Food and Drug Administration (USFDA) for its Clindamycin Hydrochloride Capsules, which represent a generic version of Pfizer's Cleocin. The approved strengths for these capsules include 75 mg, 150 mg, and 300 mg, with Glenmark set to distribute them in the U.S. through its subsidiary, Glenmark Pharmaceuticals Inc.
In May 2022, Eris Lifesciences Limited, an India-based pharmaceutical firm, acquired Oaknet Healthcare for Rs. 650 crore ($777.43 million). This acquisition allows Eris Lifesciences to penetrate the dermatology and cosmetology sectors, augmenting its product offerings and market presence with Oaknet's robust portfolio of dermatology and women's health brands. Oaknet Healthcare is an India-based company that provides clindamycin hydrochloride.
Major companies operating in the clindamycin hydrochloride market are Pfizer Inc., Abbott Laboratories, Fresenius SE & Co. KGaA, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Bausch Health Companies Inc., Hetero Drugs Limited, Sun Pharmaceutical Industries Ltd., Douglas Group, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Apotex Inc., Amneal Pharmaceuticals, Lupin Limited, Zydus Lifesciences Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd.
North America was the largest region in the clindamycin hydrochloride market in 2023. The regions covered in the clindamycin hydrochloride market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the clindamycin hydrochloride market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The clindamycin hydrochloride market consists of sales of capsules, clindamycin phosphate gel, oral suspension, and injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Clindamycin Hydrochloride Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on clindamycin hydrochloride market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for clindamycin hydrochloride ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clindamycin hydrochloride market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Oral; External Use; Intravenous Injection
2) By Indication: Treatment Of Acne; Bacterial Infections; Bone And Joint Infections; Other Infectious Diseases
3) By Application: Hospitals; Drugstores; Other Applications
Subsegments:
1) By Oral: Capsules; Tablets; Solutions
2) By External Use: Creams; Gels; Lotion
3) By Intravenous Injection: Vials; Pre-filled Syringes
Companies Mentioned:Pfizer Inc.; Abbott Laboratories; Fresenius SE & Co. KGaA; Viatris Inc.; Baxter International Inc.; Teva Pharmaceutical Industries Ltd.; Sandoz International GmbH; Bausch Health Companies Inc.; Hetero Drugs Limited; Sun Pharmaceutical Industries Ltd.; Douglas Group; Aurobindo Pharma Limited; Dr. Reddy's Laboratories Ltd.; Cipla Limited; Apotex Inc.; Amneal Pharmaceuticals; Lupin Limited; Zydus Lifesciences Ltd.; Alkem Laboratories Ltd.; Torrent Pharmaceuticals Ltd.; Taro Pharmaceutical Industries Ltd.
3. Clindamycin Hydrochloride Market Trends And Strategies
4. Clindamycin Hydrochloride Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Clindamycin Hydrochloride Growth Analysis And Strategic Analysis Framework
5.1. Global Clindamycin Hydrochloride PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Clindamycin Hydrochloride Market Growth Rate Analysis
5.4. Global Clindamycin Hydrochloride Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Clindamycin Hydrochloride Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Clindamycin Hydrochloride Total Addressable Market (TAM)
6. Clindamycin Hydrochloride Market Segmentation
6.1. Global Clindamycin Hydrochloride Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
External Use
Intravenous Injection
6.2. Global Clindamycin Hydrochloride Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Treatment Of Acne
Bacterial Infections
Bone And Joint Infections
Other Infectious Diseases
6.3. Global Clindamycin Hydrochloride Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Drugstores
Other Applications
6.4. Global Clindamycin Hydrochloride Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Capsules
Tablets
Solutions
6.5. Global Clindamycin Hydrochloride Market, Sub-Segmentation Of External Use, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Creams
Gels
Lotion
6.6. Global Clindamycin Hydrochloride Market, Sub-Segmentation Of Intravenous Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vials
Pre-filled Syringes
7. Clindamycin Hydrochloride Market Regional And Country Analysis
7.1. Global Clindamycin Hydrochloride Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Clindamycin Hydrochloride Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
